Dr. Lijie Ma | Liver Immunology | Research Excellence Award
Renji Hospital Shanghai Jiao Tong University School of Medicine | China
Dr. Lijie Ma is a clinician-scientist at Fudan University, Shanghai, China, with recognized expertise in surgical oncology, particularly in the management of retroperitoneal sarcoma, hepatobiliary tumors, and complex oncologic surgery. His scholarly work is widely cited and demonstrates sustained influence in high-impact surgical and medical journals. Dr. Ma’s research emphasizes multidisciplinary care models, outcome-driven surgical strategies, and translational approaches, including single-cell analysis, to better understand tumor progression and metastatic mechanisms. He is an active participant in extensive national and international collaborations, contributing to the development of standardized, evidence-based clinical practices. Through the integration of advanced research methodologies and real-world clinical data, Dr. Ma’s work supports improved patient care, optimized surgical outcomes, and meaningful advances in modern cancer management with broad societal relevance.
2,866
43
26
Citations
Documents
h-index
Featured Publications
The prognosis factors landscape of surgical management of retroperitoneal leiomyosarcoma: A retrospective multicenter study
– American Journal of Surgery, 2025
The evolution of surgical strategies for retroperitoneal sarcoma (RPS): Time-trend and outcome analysis from 878 consecutive resections
– Current Problems in Surgery, 2025
